Real-time enrollment status for this retinitis pigmentosa (rp) clinical trial
Current Status
Recruiting
Checked: October 28, 2026 at 6:57 PM UTC
| NCT Number | NCT07901751 |
| Recruiting Status | Recruiting |
| Condition | Retinitis Pigmentosa (RP) |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Ray Therapeutics, Inc. |
| Last Updated on CT.gov | October 28, 2026 (18 hours ago) |
As of October 28, 2026: Clinical trial NCT07901751 is currently recruiting participants. This phase2 study for retinitis pigmentosa (rp) is actively seeking new participants at 14 locations across the United States. The study is sponsored by Ray Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07901751 is actively recruiting participants as of October 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07901751 was last updated 18 hours ago (October 28, 2026). HelloStudys verifies this status automatically.